Anti-Ageing Experts Made A Million-Dollar Bet On Who Dies Last
- Dmitry Kaminskiy, senior partner of Hong Kong-based technology venture fund, Deep Knowledge Ventures, and Dr. Alex Zhavoronkov, PhD, CEO of bioinformatics company Insilico Medicine Inc. which specialises in drug discovery and drug repurposing for ageing and age-related diseases, signed a wager to indicate exactly how sure they are that science is turning the tide against the eternal problem of human ageing.
- The terms go like this: If one of the parties passes away before the other, $US1 million dollars in Insilico Medicine stock will be passed to the surviving party. The agreement will vest once both parties reach 100 years. Parties agree not to accelerate each other’s demise (i.e. try to kill each other).
- The last two years have seen the creation of major anti-ageing companies, such as Google’s Calico and J. Craig Venture’s new San Diego-based genome sequencing startup Human Longevity, (co-founded with Peter Diamandis of the X-Prize Foundation and stem cell pioneer Robert Hariri) which already has 70 million dollars in financing. Billionaires like Larry Ellison and Peter Thiel are also funding research into longevity.